Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cerebral Blood Flow Effects of Resveratrol and Piperine in Humans

This study has been completed.
Sponsor:
Information provided by:
Northumbria University
ClinicalTrials.gov Identifier:
NCT01331382
First received: April 6, 2011
Last updated: April 7, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
No publications provided by Northumbria University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):